APO RESEARCH · REPORT
Laboratory-developed Testing
Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.
Product & engineering
Understand the product.
Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.
While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.
Selected research
Industry Growth & Trends
Global Laboratory-developed Testing Industry Growth and Trends Forecast to 2032
Market perspective
Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.
Read the full market overview
While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.
According to APO Research, the global Laboratory-developed Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
This report provides a structured, data-driven view of the global Laboratory-developed Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Laboratory-developed Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Laboratory-developed Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Laboratory-developed Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Laboratory-developed Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Laboratory-developed Testing Market by Company
Adaptive Biotechnologies Corporation
Quest Diagnostics
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Biotheranostics
Adaptive Biotechnologies
Rosetta Genomics
Biodesix
Helix
Laboratory-developed Testing Segment by Type
Commercial Service
R&D
Laboratory-developed Testing Segment by Application
Genetic Testing
Oncology
Infectious Disease
Others
Laboratory-developed Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory-developed Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Laboratory-developed Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory-developed Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Laboratory-developed Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Commercial Service
- R&D
Applications
- Genetic Testing
- Oncology
- Infectious Disease
- Others
Companies covered
- Adaptive Biotechnologies Corporation
- Quest Diagnostics
- Roche
- Illumina
- Qiagen
- Eurofins
- Guardant Health
- Biotheranostics
- Adaptive Biotechnologies
- Rosetta Genomics
- Biodesix
- Helix
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Laboratory-developed Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Laboratory-developed Testing Market Size by Region (2021-2032)
- 1.4.1 Global Laboratory-developed Testing Market Size by Region (2021-2026)
- 1.4.2 Global Laboratory-developed Testing Market Size by Region (2027-2032)
- 1.5 Key Regions Laboratory-developed Testing Market Size (2021-2032)
- 1.5.1 North America Laboratory-developed Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Laboratory-developed Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Laboratory-developed Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Laboratory-developed Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Laboratory-developed Testing Market Size Growth Rate (2021-2032)
2 Laboratory-developed Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 Commercial Service
- 2.1.2 R&D
- 2.2 Global Laboratory-developed Testing Market Size by Type
- 2.2.1 Global Laboratory-developed Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Laboratory-developed Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Laboratory-developed Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Laboratory-developed Testing Market Size by Regions
- 2.3.1 North America Laboratory-developed Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Laboratory-developed Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Laboratory-developed Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Laboratory-developed Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Laboratory-developed Testing Market Size Breakdown by Type (2021-2026)
3 Laboratory-developed Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 Genetic Testing
- 3.1.2 Oncology
- 3.1.3 Infectious Disease
- 3.1.4 Others
- 3.2 Global Laboratory-developed Testing Market Size by Application
- 3.2.1 Global Laboratory-developed Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Laboratory-developed Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Laboratory-developed Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Laboratory-developed Testing Market Size by Regions
- 3.3.1 North America Laboratory-developed Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Laboratory-developed Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Laboratory-developed Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Laboratory-developed Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Laboratory-developed Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Laboratory-developed Testing Industry Trends
- 4.2 Laboratory-developed Testing Industry Drivers
- 4.3 Laboratory-developed Testing Industry Opportunities and Challenges
- 4.4 Laboratory-developed Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Laboratory-developed Testing Revenue (2021-2026)
- 5.2 Global Laboratory-developed Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Laboratory-developed Testing Key Company Headquarters & Area Served
- 5.4 Global Laboratory-developed Testing Company, Product Type & Application
- 5.5 Global Laboratory-developed Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Laboratory-developed Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Laboratory-developed Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 Laboratory-developed Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Adaptive Biotechnologies Corporation
- 6.1.1 Adaptive Biotechnologies Corporation Company Information
- 6.1.2 Adaptive Biotechnologies Corporation Business Overview
- 6.1.3 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Adaptive Biotechnologies Corporation Laboratory-developed Testing Product Portfolio
- 6.1.5 Adaptive Biotechnologies Corporation Recent Developments
- 6.2 Quest Diagnostics
- 6.2.1 Quest Diagnostics Company Information
- 6.2.2 Quest Diagnostics Business Overview
- 6.2.3 Quest Diagnostics Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Quest Diagnostics Laboratory-developed Testing Product Portfolio
- 6.2.5 Quest Diagnostics Recent Developments
- 6.3 Roche
- 6.3.1 Roche Company Information
- 6.3.2 Roche Business Overview
- 6.3.3 Roche Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Roche Laboratory-developed Testing Product Portfolio
- 6.3.5 Roche Recent Developments
- 6.4 Illumina
- 6.4.1 Illumina Company Information
- 6.4.2 Illumina Business Overview
- 6.4.3 Illumina Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Illumina Laboratory-developed Testing Product Portfolio
- 6.4.5 Illumina Recent Developments
- 6.5 Qiagen
- 6.5.1 Qiagen Company Information
- 6.5.2 Qiagen Business Overview
- 6.5.3 Qiagen Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Qiagen Laboratory-developed Testing Product Portfolio
- 6.5.5 Qiagen Recent Developments
- 6.6 Eurofins
- 6.6.1 Eurofins Company Information
- 6.6.2 Eurofins Business Overview
- 6.6.3 Eurofins Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Eurofins Laboratory-developed Testing Product Portfolio
- 6.6.5 Eurofins Recent Developments
- 6.7 Guardant Health
- 6.7.1 Guardant Health Company Information
- 6.7.2 Guardant Health Business Overview
- 6.7.3 Guardant Health Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Guardant Health Laboratory-developed Testing Product Portfolio
- 6.7.5 Guardant Health Recent Developments
- 6.8 Biotheranostics
- 6.8.1 Biotheranostics Company Information
- 6.8.2 Biotheranostics Business Overview
- 6.8.3 Biotheranostics Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Biotheranostics Laboratory-developed Testing Product Portfolio
- 6.8.5 Biotheranostics Recent Developments
- 6.9 Adaptive Biotechnologies
- 6.9.1 Adaptive Biotechnologies Company Information
- 6.9.2 Adaptive Biotechnologies Business Overview
- 6.9.3 Adaptive Biotechnologies Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Adaptive Biotechnologies Laboratory-developed Testing Product Portfolio
- 6.9.5 Adaptive Biotechnologies Recent Developments
- 6.10 Rosetta Genomics
- 6.10.1 Rosetta Genomics Company Information
- 6.10.2 Rosetta Genomics Business Overview
- 6.10.3 Rosetta Genomics Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Rosetta Genomics Laboratory-developed Testing Product Portfolio
- 6.10.5 Rosetta Genomics Recent Developments
- 6.11 Biodesix
- 6.11.1 Biodesix Company Information
- 6.11.2 Biodesix Business Overview
- 6.11.3 Biodesix Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Biodesix Laboratory-developed Testing Product Portfolio
- 6.11.5 Biodesix Recent Developments
- 6.12 Helix
- 6.12.1 Helix Company Information
- 6.12.2 Helix Business Overview
- 6.12.3 Helix Laboratory-developed Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Helix Laboratory-developed Testing Product Portfolio
- 6.12.5 Helix Recent Developments
7 North America
- 7.1 North America Laboratory-developed Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Laboratory-developed Testing Market Size by Country (2021-2026)
- 7.3 North America Laboratory-developed Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Laboratory-developed Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Laboratory-developed Testing Market Size by Country (2021-2026)
- 8.3 Europe Laboratory-developed Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Laboratory-developed Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Laboratory-developed Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Laboratory-developed Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Laboratory-developed Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Laboratory-developed Testing Market Size by Country (2021-2026)
- 10.3 South America Laboratory-developed Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Laboratory-developed Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Laboratory-developed Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Laboratory-developed Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst